申请人:Boehringer Ingelheim International GmbH
                            
                            
                                公开号:US10875852B2
                            
                            
                                公开(公告)日:2020-12-29
                            
                            
The present invention encompasses compounds of the formula (I)
wherein the groups A, Cy, X1 and Y are defined herein, which are suitable for the treatment of diseases related to BTK, process of making, pharmaceutical preparations which contain compounds and their methods of use.
                            本发明包括式 (I) 的化合物
其中基团 A、Cy、X1 和 Y 在本文中定义,适用于治疗与 BTK 有关的疾病、制造工艺、含有化合物的药物制剂及其使用方法。